Abstracts presented at the Annual Scientific Meeting of the Stroke Society of Australasia and Stroke Nursing Symposium, 2005
Monitoring medical research conduct: why, how and by whom?
Pharmaceutical Benefits Scheme criteria for the use of tumour necrosis factor-α inhibitors in the treatment of ankylosing spondylitis in Australia: are they evidence based?
Measurement of faecal fat excretion: an evaluation of attitudes and practices of Australian gastroenterologists
Lust; Nandurkar; Gibson
Communication deficiencies in research and monitoring by ethics committees
Karunaratne; Myles; Ago; Komesaroff
How have we been managing chronic obstructive pulmonary disease in Australia?
Matheson; Abeysena; Raven; Skoric; Johns; Abramson; Walters
Management of chronic hepatitis B virus infection: a new era of disease control
Cardiac resynchronisation therapy for heart failure
Mariani; Gould; Broughton; Kaye
Consent in crisis: the need to reconceptualize consent to tissue banking research
Lipworth; Ankeny; Kerridge
An apparently sporadic paraganglioma with an SDHB gene germline mutation presenting at age 68 years
Elston; Benn; Robinson; Conaglen
Medication accuracy and general practitioner referral letters
Clinical findings in Niemann–Pick disease type B
Obstructive sleep apnoea induced atrial fibrillation
Cardiac amyloidosis—sustained clinical and free light chain response to low dose thalidomide and corticosteroids
Stool antigen testing for the diagnosis and confirmation of eradication of Helicobacter pylori infection
Wallace; Schluter; Webb